Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2026 Nov 1:2025.05.02.651303. [Version 3] doi: 10.1101/2025.05.02.651303

EBF1 controls an embryonic artery-forming niche that reactivates in pulmonary arterial hypertension

Wen (Amy) Tian, Timothy Ting-Hsuan Wu, Shenbiao Gu, Seunghee Lee, Hanqiu Zhao, Adam M Andruska, Kyle K Song, Jason L Chang, Cerianne Huang, Ryan Vinh, Dongeon Kim, Yu Zhu, Evan Bao, Stuti Agarwal, Dan YI, Aiqing Cao, Junliang Pan, Peter N Kao, Tushar Desai, Ke Yuan, Roham Zamanian, Lawrence S Prince, Lindsay D Butcher, Vinicio de Jesus Perez, Roger Johns, Xinguo Jiang, Patrick E Bogard, Jason Hong, Marlene Rabinovitch, Kristy Red-Horse, Mark A Krasnow, Zhiyu Dai, Mark R Nicolls
PMCID: PMC13733740  PMID: 42990153

Abstract

Developmental programs that orchestrate cell fate and tissue architecture during organogenesis can cause disease when reactivated in adults. Here we identify a population of endothelial cells (ECs) defined by the pioneer factor early B cell factor 1 (EBF1) that controls both pulmonary artery (PA) morphogenesis and pulmonary arterial hypertension (PAH). During embryonic development, the PA emerges from an endothelial niche harbored within the vascular plexus, where Aplnr+ endothelial progenitors give rise to both arterial ECs and EBF1+ ECs. Rather than incorporating directly into the PA intima, EBF1+ ECs control the branching and maturation of the PA tree through paracrine vasculotrophic signals that direct plexus expansion, arterialization, and mural cell recruitment. Although essential for development, most EBF1+ ECs disappear upon completion of PA morphogenesis, leaving only a rare residual population within the adult Aplnr+ gCap compartment. In PAH, vascular injury reactivates the EBF1 program through recruitment of the pre-existing Ebf1 lineage together with an additional contribution consistent with de novo Ebf1 induction in gCaps, reconstituting this artery-forming niche in a maladaptive reprise of PA development. Unlike their transient embryonic counterparts, these EBF1+ ECs persist within occlusive intimal lesions and express vasculotrophic signals associated with pathological PA remodeling. Combined with endothelial injury, gCap-specific Ebf1 overexpression drives a coordinated program of neo-arterialization, occlusive vascular remodeling, and severe PAH. Conversely, gCap-specific genetic deletion of Ebf1 in mice and endothelial-targeted AAV-mediated Ebf1 knockdown in rats protect against disease, showing that endothelial EBF1 is required for PAH pathogenesis. These findings demonstrate that reactivation and persistence of a transient embryonic artery-forming niche in adulthood drive pathological vascular remodeling and PAH.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES